Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

Doxycycline hyclate controlled-release - CollaGenex Pharmaceuticals

Drug Profile

Doxycycline hyclate controlled-release - CollaGenex Pharmaceuticals

Alternative Names: Controlled-release doxycycline hyclate; Doxycycline hyclate sustained release - CollaGenex/Shire; Periostat II; Periostat MR; Periostat SR; Sustained-release doxycycline hyclate - CollaGenex

Latest Information Update: 04 Feb 2008

Price : $50 *
  • Adis is an information provider. We do not sell or distribute actual drugs.
  • Final gross price and currency may vary according to local VAT and billing address.
  • Your purchase entitles you to full access to the information contained in our drug profile at the time of purchase.
  • A link to download a PDF version of the drug profile will be included in your email receipt.

At a glance

  • Originator CollaGenex Pharmaceuticals
  • Developer Supernus Pharmaceuticals
  • Class Antibacterials; Collagenases; Skin disorder therapies; Tetracyclines
  • Mechanism of Action Collagenase inhibitors
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.


Highest Development Phases

  • Discontinued Periodontal disorders

Most Recent Events

  • 23 Nov 2004 CollaGenex has completed enrolment in a phase III trial for adult periodontitis in the US and UK
  • 05 Apr 2004 Phase-III clinical trials in Periodontal disorders in United Kingdom (PO)
  • 05 Apr 2004 Phase-III clinical trials in Periodontal disorders in USA (PO)
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top